Peer-reviewedCC BY-NC-NDInternal Medicine
Effect of Transthyretin Stabilizer in Transthyretin Cardiac Amyloidosis
Related
- Gender and Racial Distribution of Transthyretin Stabilizer Therapy in Patients With Transthyretin Cardiac Amyloidosis.
- A Progressive 99mTc-MDP Uptake in Transthyretin Cardiac Amyloidosis
- The Progressive Cardiac Uptake of 99mTc-MDP as a Clue to Transthyretin Amyloidosis
- Transcatheter Mitral Edge-to-edge Repair in Patients with Transthyretin Cardiac Amyloidosis: A Four-case Series
- Hydroxychloroquine Cardiotoxicity Mimicking Transthyretin Cardiac Amyloidosis in a Patient With HFpEF
BibTeX
@article{kubo2026effect,
title = {{Effect of Transthyretin Stabilizer in Transthyretin Cardiac Amyloidosis}},
author = {Toru Kubo and Yuri Ochi and Yuichi Baba and Hiroaki Kitaoka},
journal = {Internal Medicine},
year = {2026},
month = sep,
doi = {10.2169/internalmedicine.6741-25},
url = {https://www.jstage.jst.go.jp/article/internalmedicine/65/18/65_6741-25/_article},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Effect of Transthyretin Stabilizer in Transthyretin Cardiac Amyloidosis
AU - Toru Kubo
AU - Yuri Ochi
AU - Yuichi Baba
AU - Hiroaki Kitaoka
PY - 2026
DA - 2026/09/15
JO - Internal Medicine
DO - 10.2169/internalmedicine.6741-25
UR - https://www.jstage.jst.go.jp/article/internalmedicine/65/18/65_6741-25/_article
SN - 1349-7235
SN - 0918-2918
ER -